This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global pharmaceutical quality management software market report highlights that the market was valued at $472.6 million in 2020 and is expected to reach $3,717.7 million by the end of 2030. The market is expected to grow at a CAGR of 22.91% during the forecast period from 2021 to 2030.
Market Report Coverage - Pharmaceutical Quality Management Software
Market Segmentation
- Application - Corrective Action Preventive Action (CAPA) Management, Audit Management, Document Management, Change Management, Training Management, Risk Management, Complaints Management, Regulatory and Compliance Management, Non-Conformances Handling, Supplier Quality Management, Inspection Management, Equipment Management, and Others.
- Deployment Model - On-Cloud, Web-Based, and On-Premises
- End User - Pharmaceutical, Life Sciences, and Biotechnology Companies, Contract Research Organizations, and Others
Regional Segmentation
- North America - U.S. and Canada
- Europe - Germany, U.K., France, Spain, Italy, and Rest-of-Europe
- Asia-Pacific - Japan, China, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific
- Rest-of-the-World - Brazil, Mexico, and Rest of Rest-of-the-World
Market Growth Drivers
- Increasing Cost of Drugs Manufacturing
- Constantly Evolving Regulations
- Growing Technology Adoption in Pharmaceutical Industry
Market Challenges
- Security Concerns Pertaining to On-Cloud Deployment
- Lack of Regulations for Pharmaceutical Quality Management Software
Market Opportunities
- Synergies Between Pharmaceutical Quality Management Software Developers and Local End User
- Development of Solutions Based on Platform-as-a-Service Business Model
Key Companies Profiled
ANTARES VISION S.p.A, AssurX, Inc., AXSource, CLARIVATE PLC., ComplianceQuest, Dassault Systèmes, EtQ Management Consultants, Inc., Honeywell International Inc., Ideagen Plc., IQVIA HOLDINGS INC., LogicGate, Inc, MasterControl, PTC Inc., Sarjen Systems Pvt. Ltd., Qualio, Veeva Systems Inc.
How This Report Can Add Value
Assuming that the reader is a developer of pharmaceutical quality management software, they will be able to do the following:
- Understand their position as compared to some of the key players in the market
- Stay updated with novel technology integration, features, and the latest developments in the market
- Understand the impact of COVID-19 on the adoption of pharmaceutical QMS and the entry barriers as a result of it
- Gain insights into which regions to target globally based on factors such as the technology adoption in the pharmaceutical industry and government established regulations
- To gain insights into end-user perception with respect to the adoption of pharmaceutical QMS systems
- Identify some of the key players in the market and understand their valuable contribution
Key Questions Answered in the Global Pharmaceutical Quality Management Market Report
- How did the COVID-19 pandemic impact the adoption of pharmaceutical quality management software by various pharmaceutical and life sciences companies?
- What is the outlook for the global pharmaceutical quality management software market during the forecast period 2021-2030?
- What are the key trends influencing the global pharmaceutical quality management software market? How will they influence the market in short-, mid-, and long-term duration?
- What is the end user perception toward pharmaceutical quality management software?
- How is the patent landscape for pharmaceutical quality software? Which country/cluster witnessed the highest patent filing from January 2014-June 2021?
- What are the key factors impacting the global pharmaceutical quality management software market? What will be their impact in short-, mid-, and long-term duration?
- What are the key opportunities areas in the global pharmaceutical quality management software market? What is their potential in short-, mid-, and long-term duration?
- What are the key strategies adopted by companies in the global pharmaceutical quality management software market?
- What are the key application areas of the global pharmaceutical quality management software market? Which application is expected to hold the highest growth potential during the forecast period 2021-2030?
- What is the preferred deployment model for the global pharmaceutical quality management software? What is the growth potential of various deployment models present in the market?
- Who are the key end users of pharmaceutical quality software? What is their respective share in the global pharmaceutical quality management software market?
- Which regional market is expected to hold the highest growth potential in the global pharmaceutical quality management software market during the forecast period 2021-2030?
- Which are the key players in the global pharmaceutical quality management software market?
Global Pharmaceutical Quality Management Software Market Industry Overview
The manufacture of drugs and pharmaceutical products passes through various processing steps, each of which requires monitoring to ensure the safety, efficacy, and quality of the manufactured product. Traditional paper-based quality management systems are associated with various drawbacks that can be overcome by software-based quality management systems.
While the pharmaceutical quality management software market is still in its niche stage, the market is anticipated to grow rapidly owing to increasing technology adoption in the pharmaceutical industry, increasing cost of drug manufacturing, and evolving regulations. Currently, a few large pharmaceutical companies have adopted electronic quality management systems in order to automate their processes. With increasing technology adoption in the pharmaceutical industry, going forward, smaller companies are expected to implement software-based systems from the beginning itself.
The COVID-19 pandemic has further accelerated the digital transformation of the pharmaceutical industry. This positive impact is attributed to factors such as travel restrictions and the emerging concept of working and communicating remotely.
Global Pharmaceutical Quality Management Software Market Drivers
The factors driving the growth of the market include the increasing cost of drug manufacturing, constantly evolving regulations, and growing technology adoption in the pharmaceutical industry. Pharmaceutical companies spend up to billions of dollars in the manufacture of a new drug, thereby increasing the demand for automating manufacturing processes. The benefits associated with paper-based quality management systems are overcome by software-based quality management systems, presenting a lucrative market for pharmaceutical quality management software.
Furthermore, increasing demand by pharmaceutical companies to comply with regulatory requirements in order to compete with other players in the market is another factor driving the growth of the market.
Global Pharmaceutical Quality Management Software Market Challenges
The factors restraining the growth of the global pharmaceutical quality management software include security concerns pertaining to on-cloud deployment and the lack of well-established regulations governing pharmaceutical quality management software systems. Data breach incidents cause the pharmaceutical industry to suffer both monetary losses as well as breaches of customer trust. Additionally, while emerging economies in Asia-Pacific and Rest-of-the-World present a huge potential for growth of the pharmaceutical quality management software market, currently, market penetration in the region is challenging owing to factors such as lack of technology integration in the pharmaceutical industry and high upfront costs associated with the purchase of software.
However, the COVID-19 pandemic has countered these challenges and thus, positively impacted the digital transformation of the pharmaceutical industry.
Global Pharmaceutical Quality Management Software Market Opportunities
Synergies between pharmaceutical QMS developers and local end users and the development of solutions based on platform-as-a-service business model hold immense potential for the growth of the global pharmaceutical quality management software market.
The development of solutions based on the platform-as-a-service model is a novel model for running applications such as quality management software wherein a third party maintains the hardware and software infrastructure and delivers it to users over the internet. The software developers are adopting the PaaS solutions due to their simplicity, scalability, and reliability.
Impact of COVID-19 on the Global Pharmaceutical Quality Management Software Market
A paradigm shift in consumer preference from a paper-based management system to a digital cloud-based system has been witnessed in the past decade. The pandemic had a positive impact on the global pharmaceutical quality management software market. This is attributed to government-imposed restrictions during the lockdown and the shift towards working remotely. The realized benefits are expected to influence user perception post-COVID as well. Some of these benefits include:
- Time saving due to systematic categorization and storage of documentation
- Convenient approach to storage, manage and make sense of large amounts of data
- Higher revenue stream, in the long run, owing to cost savings
- Cost savings are realized in areas such as non-conformity and complaints
- Streamlined workflow enabling more efficient communication and collaboration within the organization as well as with clients
Market Segmentation
Global Pharmaceutical Quality Management Software Market (by Deployment Model)
The global pharmaceutical quality management software market has been segmented on the basis of deployment model into three broad categories, namely, on-cloud, web-based, and on-premises.
The on-cloud deployment model offers significant benefits over the traditional on-premises software or paper-based system. With the cloud-based system, it is easier to upgrade to the electronic QMS. The model can be accessed remotely in a highly secured environment. The model is also easily scalable, which allows clients to add more users and storage according to the business needs in the future.
Global Pharmaceutical Quality Management Software Market (by Application)
The global pharmaceutical quality management software market has been segmented on the basis of application into corrective action preventive action (CAPA) management, audit management, document management, change management, training management, risk management, complaints management, regulatory and compliance management, non-conformances handling, supplier quality management, inspection management, equipment management, and others.
Rising technology adoption in the pharmaceutical industry and increasing demand to automate processes to ensure regulatory compliance are major factors driving the growth of various quality management application areas.
Global Pharmaceutical Quality Management Software Market (by End User)
The global pharmaceutical quality management software market has been segmented on the basis of end users into three categories, namely, pharmaceutical, life sciences companies, and biotechnology companies, contract research organizations, and others.
Pharmaceutical, life sciences, and biotechnology companies are the major end users of the global pharmaceutical quality management software market. The adoption of quality management software is increasing in these industries due to the rapid growth of industries and ease of use. With the adoption of pharmaceutical QMS systems, the industries can better control, manage compliance, and assess the products for quality.
Contract research organizations (CRO) are the emerging end-user segment of the global pharmaceutical quality management software market. The trend is driven by both pharmaceutical and biotechnology companies outsourcing certain processes to CROs.
Global Pharmaceutical Quality Management Software Market (by Region)
The different regions covered under the global urgent care apps market include North America, Europe, Asia-Pacific, and Rest-of-the-World.
North America and Europe are two of the largest markets for pharmaceutical quality management software. This is attributed to increasing technology integration in the pharmaceutical industry. While developing countries such as those in Asia-Pacific and the Rest-of-the-World currently offer challenges to pharmaceutical QMS developers to enter the market in these regions, they are expected to register strong growth in the adoption of pharmaceutical quality management software in the near future.
Key Market Players and Competition Synopsis
Some of the key players operating in the market include ANTARES VISION S.p.A, AssurX, Inc., AXSource, CLARIVATE PLC., ComplianceQuest, Dassault Systèmes, EtQ Management Consultants, Inc., Honeywell International Inc., Ideagen Plc., IQVIA HOLDINGS INC., LogicGate, Inc, MasterControl, PTC Inc., Sarjen Systems Pvt. Ltd., Qualio, and Veeva Systems Inc.
In the past few years, the global pharmaceutical quality management software market has witnessed several strategic and technological developments undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been partnerships followed by funding activities.
Table of Contents
1 Market
1.1 Market Outlook
1.1.1 Key Findings and Opportunity Assessment
1.1.1.1 Key Findings
1.1.1.2 Opportunity Assessment
1.1.2 Growth Scenarios
1.1.2.1 Realistic Growth Scenario
1.1.2.2 Optimistic Growth Scenario
1.1.2.3 Pessimistic/Conservative Growth Scenario
1.2 Industry Analysis
1.2.1 Key Trends
1.2.1.1 Potential Analysis
1.2.1.1.1 Short-Term Potential (2-4 Years)
1.2.1.1.2 Mid-Term Potential (5-10 Years)
1.2.1.1.3 Long-Term Potential (8-12 Years)
1.2.2 Value Chain Analysis
1.2.3 Readiness Index
1.2.4 Technology Adoption Matrix
1.2.5 Cost Benefit Analysis
1.2.6 End User Perception
1.2.7 Case Studies
1.2.7.1 Case Study: Alphazyme and Qualio
1.2.7.2 Case Study: AL Andalous and AmpleLogic
1.2.8 Patent Analysis
1.2.8.1 Patent Analysis, by Year
1.2.8.2 Patent Analysis, by Country/Cluster
1.3 Impact of COVID-19 on Global Pharmaceutical Quality Management Software Market
1.3.1 Impact on Adoption of Pharmaceutical Quality Management Software
1.3.2 Impact on Market Size
1.3.2.1 Scenario Comparison Analysis
1.3.3 Future Outlook and Recommendations
1.4 Market Dynamics
1.4.1 Market Drivers
1.4.1.1 Increasing Cost of Drugs Manufacturing
1.4.1.2 Constantly Evolving Regulations
1.4.1.3 Growing Technology Adoption in Pharmaceutical Industry
1.4.2 Market Restraints
1.4.2.1 Security Concerns Pertaining to On-Cloud Deployment
1.4.2.2 Lack of Regulations for Pharmaceutical Quality Management Software
1.4.3 Impact Analysis
1.4.4 Market Opportunities
1.4.4.1 Synergies Between Pharmaceutical Quality Management Software Developers and Local End User
1.4.4.2 Development of Solutions Based on Platform-as-a-Service Business Model
1.4.4.3 Opportunities Analysis (Short-, Mid-, and Long-Term Duration)
1.4.4.3.1 Short-Term Impact
1.4.4.3.2 Mid-Term Impact
1.4.4.3.3 Long-Term Impact
1.4.5 Business Model Analysis
2 Application
2.1 Global Pharmaceutical Quality Management Software Market (by Application)
2.1.1 Opportunity Assessment
2.1.2 Growth-Share Matrix
2.1.3 Corrective Action Preventive Action (CAPA) Management
2.1.4 Audit Management
2.1.5 Document Management
2.1.6 Change Management
2.1.7 Training Management
2.1.8 Risk Management
2.1.9 Complaints Management
2.1.10 Regulatory and Compliance Management
2.1.11 Non-Conformances Handling
2.1.12 Supplier Quality Management
2.1.13 Inspection Management
2.1.14 Equipment Management
2.1.15 Others
2.2 Global Pharmaceutical Quality Management Software Market (by End User)
2.2.1 Opportunity Assessment
2.2.2 Pharmaceutical, Life Sciences, and Biotechnology Companies
2.2.3 Contract Research Organizations
2.2.4 Others
3 Product
3.1 Global Pharmaceutical Quality Management Software Market (by Deployment Model)
3.1.1 Opportunity Assessment
3.1.2 Growth-Share Matrix
3.1.3 On-Cloud
3.1.4 Web-Based
3.1.5 On-Premises
4 Region
4.1 North America
4.1.1 Market
4.1.1.1 Key Findings and Opportunity Assessment
4.1.1.2 Market Dynamics: Impact Analysis
4.1.1.3 Regulations in North America
4.1.1.4 Market Size and Forecast
4.1.2 Application
4.1.2.1 North America Pharmaceutical Quality Management Software Market (by End User)
4.1.3 Product
4.1.3.1 North America Pharmaceutical Quality Management Software Market (by Deployment Model)
4.1.4 North America (by Country)
4.1.4.1 U.S.
4.1.4.1.1 Market
4.1.4.1.1.1 Buyer Attributes
4.1.4.1.1.2 Market Drivers
4.1.4.1.1.3 Market Restraints
4.1.4.2 Canada
4.1.4.2.1 Market
4.1.4.2.1.1 Buyer Attributes
4.1.4.2.1.2 Market Drivers
4.1.4.2.1.3 Market Restraints
4.2 Europe
4.2.1 Market
4.2.1.1 Key Findings and Opportunity Assessment
4.2.1.2 Market Dynamics: Impact Analysis
4.2.1.3 Regulations in Europe
4.2.1.4 Market Size and Forecast
4.2.2 Application
4.2.2.1 Europe Pharmaceutical Quality Management Software Market (by End User)
4.2.3 Product
4.2.3.1 Europe Pharmaceutical Quality Management Software Market (by Deployment Model)
4.2.4 Europe (by Country)
4.2.4.1 Germany
4.2.4.1.1 Market
4.2.4.1.1.1 Buyer Attributes
4.2.4.1.1.2 Market Drivers
4.2.4.1.1.3 Market Restraints
4.2.4.2 U.K.
4.2.4.2.1 Market
4.2.4.2.1.1 Buyer Attributes
4.2.4.2.1.2 Market Drivers
4.2.4.2.1.3 Market Restraints
4.2.4.3 France
4.2.4.3.1 Market
4.2.4.3.1.1 Buyer Attributes
4.2.4.3.1.2 Market Drivers
4.2.4.3.1.3 Market Restraints
4.2.4.4 Italy
4.2.4.4.1 Market
4.2.4.4.1.1 Buyer Attributes
4.2.4.4.1.2 Market Drivers
4.2.4.4.1.3 Market Restraints
4.2.4.5 Spain
4.2.4.5.1 Market
4.2.4.5.1.1 Buyer Attributes
4.2.4.5.1.2 Market Drivers
4.2.4.5.1.3 Market Restraints
4.2.4.6 Rest-of-Europe
4.2.4.6.1 Market
4.2.4.6.1.1 Buyer Attributes
4.2.4.6.1.2 Market Drivers
4.2.4.6.1.3 Market Restraints
4.3 Asia-Pacific
4.3.1 Market
4.3.1.1 Key Findings and Opportunity Assessment
4.3.1.2 Market Dynamics: Impact Analysis
4.3.1.3 Regulations in Asia-Pacific
4.3.1.4 Market Size and Forecast
4.3.2 Application
4.3.2.1 Asia-Pacific Pharmaceutical Quality Management Software Market (by End User)
4.3.3 Product
4.3.3.1 Asia-Pacific Pharmaceutical Quality Management Software Market (by Deployment Model)
4.3.4 Asia-Pacific (by Country)
4.3.4.1 Japan
4.3.4.1.1 Market
4.3.4.1.1.1 Buyer Attributes
4.3.4.1.1.2 Market Drivers
4.3.4.1.1.3 Market Restraints
4.3.4.2 China
4.3.4.2.1 Market
4.3.4.2.1.1 Buyer Attributes
4.3.4.2.1.2 Market Drivers
4.3.4.2.1.3 Market Restraints
4.3.4.3 South Korea
4.3.4.3.1 Market
4.3.4.3.1.1 Buyer Attributes
4.3.4.3.1.2 Market Drivers
4.3.4.3.1.3 Market Restraints
4.3.4.4 India
4.3.4.4.1 Market
4.3.4.4.1.1 Buyer Attributes
4.3.4.4.1.2 Market Drivers
4.3.4.4.1.3 Market Restraints
4.3.4.5 Australia and New Zealand
4.3.4.5.1 Market
4.3.4.5.1.1 Buyer Attributes
4.3.4.5.1.2 Market Drivers
4.3.4.5.1.3 Market Restraints
4.3.4.6 Rest-of-Asia-Pacific
4.3.4.6.1 Market
4.3.4.6.1.1 Buyer Attributes
4.3.4.6.1.2 Market Drivers
4.3.4.6.1.3 Market Restraints
4.4 Rest-of-the-World
4.4.1 Market
4.4.1.1 Key Findings and Opportunity Assessment
4.4.1.2 Market Dynamics: Impact Analysis
4.4.1.3 Regulations in Rest-of-the-World
4.4.1.4 Market Size and Forecast
4.4.2 Application
4.4.2.1 Rest-of-the-World Pharmaceutical Quality Management Software Market (by End User)
4.4.3 Product
4.4.3.1 Rest-of-the-World Pharmaceutical Quality Management Software Market (by Deployment Model)
4.4.4 Rest-of-the-World (by Country)
4.4.4.1 Brazil
4.4.4.1.1 Market
4.4.4.1.1.1 Buyer Attributes
4.4.4.1.1.2 Market Drivers
4.4.4.1.1.3 Market Restraints
4.4.4.2 Mexico
4.4.4.2.1 Market
4.4.4.2.1.1 Buyer Attributes
4.4.4.2.1.2 Market Drivers`
4.4.4.2.1.3 Market Restraints
4.4.4.3 Rest of Rest-of-the-World
4.4.4.3.1 Market
4.4.4.3.1.1 Buyer Attributes
4.4.4.3.1.2 Market Drivers
4.4.4.3.1.3 Market Restraints
5 Markets - Competitive Benchmarking & Company Profiles
5.1 Competitive Benchmarking
5.2 Key Strategies
5.2.1 Partnerships, Alliances, and Business Expansion
5.2.2 New Offerings
5.2.3 Funding Activities
5.2.4 Mergers and Acquisitions
5.2.5 Regulatory and Legal
5.3 Market Share Analysis
5.4 Company Profiles
5.4.1 ANTARES VISION S.p.A
5.4.1.1 Company Overview
5.4.1.2 ANTARES VISION S.p.A in Global Pharmaceutical Quality Management Software Market
5.4.1.3 Product Portfolio
5.4.1.4 Financials
5.4.1.5 Recent Developments
5.4.1.6 SWOT Analysis
5.4.2 AssurX, Inc.
5.4.2.1 Company Overview
5.4.2.2 Role of AssurX, Inc. in Global Pharmaceutical Quality Management Software Market
5.4.2.3 Product Portfolio
5.4.2.4 SWOT Analysis
5.4.3 AXSource
5.4.3.1 Company Overview
5.4.3.2 Role of AXSource in Global Pharmaceutical Quality Management Software Market
5.4.3.3 Product Portfolio
5.4.3.4 Recent Developments
5.4.3.5 SWOT Analysis
5.4.4 CLARIVATE PLC.
5.4.4.1 Company Overview
5.4.4.2 Role of CLARIVATE PLC. in Global Pharmaceutical Quality Management Software Market
5.4.4.3 Product Portfolio
5.4.4.4 Financials
5.4.4.5 Recent Developments
5.4.4.6 SWOT Analysis
5.4.5 ComplianceQuest
5.4.5.1 Company Overview
5.4.5.2 Role of ComplianceQuest in Global Pharmaceutical Quality Management Software Market
5.4.5.3 Product Portfolio
5.4.5.4 Recent Developments
5.4.5.5 SWOT Analysis
5.4.6 Dassault Systèmes
5.4.6.1 Company Overview
5.4.6.2 Role of Dassault Systèmes in Global Pharmaceutical Quality Management Software Market
5.4.6.3 Product Portfolio
5.4.6.4 Financials
5.4.6.5 SWOT Analysis
5.4.7 EtQ Management Consultants, Inc.
5.4.7.1 Company Overview
5.4.7.2 Role of EtQ Management Consultants, Inc. in Global Pharmaceutical Quality Management Software Market
5.4.7.3 Product Portfolio
5.4.7.4 Recent Developments
5.4.7.5 SWOT Analysis
5.4.8 Honeywell International Inc.
5.4.8.1 Company Overview
5.4.8.2 Role of Honeywell International Inc. in Global Pharmaceutical Quality Management Software Market
5.4.8.3 Product Portfolio
5.4.8.4 Financials
5.4.8.5 Recent Developments
5.4.8.6 SWOT Analysis
5.4.9 Ideagen Plc.
5.4.9.1 Company Overview
5.4.9.2 Role of Ideagen Plc. in Global Pharmaceutical Quality Management Software Market
5.4.9.3 Product Portfolio
5.4.9.4 Financials
5.4.9.5 Recent Developments
5.4.9.6 SWOT Analysis
5.4.10 IQVIA HOLDINGS INC.
5.4.10.1 Company Overview
5.4.10.2 Role of IQVIA HOLDINGS INC. in Global Pharmaceutical Quality Management Software Market
5.4.10.3 Product Portfolio
5.4.10.4 Financials
5.4.10.5 SWOT Analysis
5.4.11 LogicGate, Inc
5.4.11.1 Company Overview
5.4.11.2 Role of LogicGate, Inc. in Global Pharmaceutical Quality Management Software Market
5.4.11.3 Product Portfolio
5.4.11.4 Recent Developments
5.4.11.5 SWOT Analysis
5.4.12 MasterControl
5.4.12.1 Company Overview
5.4.12.2 Role of MasterControl in Global Pharmaceutical Quality Management Software Market
5.4.12.3 Product Portfolio
5.4.12.4 Recent Developments
5.4.12.5 SWOT Analysis
5.4.13 PTC Inc.
5.4.13.1 Company Overview
5.4.13.2 Role of PTC Inc. in Global Pharmaceutical Quality Management Software Market
5.4.13.3 Product Portfolio
5.4.13.4 Financials
5.4.13.5 Recent Developments
5.4.13.6 SWOT Analysis
5.4.14 Sarjen Systems Pvt. Ltd.
5.4.14.1 Company Overview
5.4.14.2 Role of Sarjen Systems Pvt. Ltd. in the Global Pharmaceutical Quality Management Software Market
5.4.14.3 Product Portfolio
5.4.14.4 SWOT Analysis
5.4.15 Qualio
5.4.15.1 Company Overview
5.4.15.2 Role of Qualio in Global Pharmaceutical Quality Management Software Market
5.4.15.3 Product Portfolio
5.4.15.4 Recent Developments
5.4.15.5 SWOT Analysis
5.4.16 Veeva Systems Inc.
5.4.16.1 Company Overview
5.4.16.2 Role of Veeva Systems Inc. in Global Pharmaceutical Quality Management Software Market
5.4.16.3 Product Portfolio
5.4.16.4 Financials
5.4.16.5 SWOT Analysis
5.5 Company Snapshots
5.5.1 Key IT/Conglomerate Companies
5.4.1.2 IBM
5.5.1.1.1 Company Overview
5.5.1.1.2 Role of IBM in Global Pharmaceutical Quality Management Software Market
5.5.1.2 Oracle
5.5.1.2.1 Company Overview
5.5.1.2.2 Role of Oracle in Global Pharmaceutical Quality Management Software Market
5.5.1.3 SAP SE
5.5.1.3.1 Company Overview
5.5.1.3.2 Role of SAP SE in Global Pharmaceutical Quality Management Software Market
5.5.1.4 Siemens AG
5.5.1.4.1 Company Overview
5.5.1.4.2 Role Siemens AG in Global Pharmaceutical Quality Management Software Market
5.5.1.5 Tata Elxsi
5.5.1.5.1 Company Overview
5.5.1.5.2 Role of Tata Elxsi in Global Pharmaceutical Quality Management Software Market
6 Research Methodology
6.1 Data Sourcing
6.1.1 Primary Data Sourcing
6.1.2 Secondary Data Sourcing
6.2 Data Triangulation
6.3 Market Estimation
6.3.1 Factors for Data Prediction and Modeling
6.4 Assumptions and Limitations
List of Figures
Figure 1: Global Pharmaceutical Quality Management Software Market, Dynamics Impact Analysis
Figure 2: Global Pharmaceutical Quality Management Software Market (by Region), $Million, 2020 and 2030
Figure 3: Global Pharmaceutical Quality Management Software Market Incremental Opportunity, $Million, 2020-2030
Figure 4: Global Pharmaceutical Quality Management Software Market Segmentation
Figure 5: Global Pharmaceutical Quality Management Software Market, Realistic Growth Scenario, $Million, 2020-2030
Figure 6: Global Pharmaceutical Quality Management Software Market, Optimistic Growth Scenario, $Million, 2020-2030
Figure 7: Global Pharmaceutical Quality Management Software Market, Pessimistic/Conservative Growth Scenario, $Million, 2020-2030
Figure 8: Global Pharmaceutical Quality Management Software Market, Key Trends
Figure 9: Global Pharmaceutical Quality Management Software Market, Value Chain Analysis
Figure 10: Readiness Index: Pharmaceutical Quality Management Software
Figure 11: Pharmaceutical Quality Management Software Market: Technology Adoption Matrix
Figure 12: Global Pharmaceutical Quality Management Software Market, Patent Analysis (by Year), January 2014-June 2021
Figure 13: Global Pharmaceutical Quality Management Software Market, Patent Analysis (by Country), January 2014-June 2021
Figure 14: Global Pharmaceutical Quality Management Software Market, COVID-19 Impact Analysis (With COVID-19 Vs. Without COVID-19)
Figure 15: COVID-19 Impact Analysis on Global Pharmaceutical Quality Management Software Market Adoption
Figure 16: Cloud-Enabled Pharmaceutical Quality Management Software Ecosystem
Figure 17: Global Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
Figure 18: Most Common Business Models for Pharmaceutical Quality Management Software
Figure 19: Global Pharmaceutical Quality Management Software Market (by Application)
Figure 20: Global Pharmaceutical Quality Management Software Market Incremental Opportunity (by Application), $Million, 2020-2030
Figure 21: Global Pharmaceutical Quality Management Software Market Growth-Share Matrix (by Application), 2020-2030
Figure 22: Process of Initiating and Implementing a CAPA
Figure 23: Global Pharmaceutical Quality Management Software Market (CAPA Management), $Million, 2020-2030
Figure 24: Global Pharmaceutical Quality Management Software Market (Audit Management), $Million, 2020-2030
Figure 25: Workflow of a Typical Pharmaceutical Document Management Software System
Figure 26: Global Pharmaceutical Quality Management Software Market (Document Management), $Million, 2020-2030
Figure 27: Changes Reported Through Change Management in Pharmaceutical Industry
Figure 28: Global Pharmaceutical Quality Management Software Market (Change Management), $Million, 2020-2030
Figure 29: Global Pharmaceutical Quality Management Software Market (Training Management), $Million, 2020-2030
Figure 30: Global Pharmaceutical Quality Management Software Market (Risk Management), $Million, 2020-2030
Figure 31: Workflow in a Pharmaceutical Company on Receiving a Complaint
Figure 32: Global Pharmaceutical Quality Management Software Market (Complaints Management), $Million, 2020-2030
Figure 33: Global Pharmaceutical Quality Management Software Market (Regulatory and Compliance Management), $Million, 2020-2030
Figure 34: Workflow on Non-Conformance Handling
Figure 35: Global Pharmaceutical Quality Management Software Market (Non-Conformance Handling), $Million, 2020-2030
Figure 36: Global Pharmaceutical Quality Management Software Market (Supplier Quality Management), $Million, 2020-2030
Figure 37: Global Pharmaceutical Quality Management Software Market (Inspection Management), $Million, 2020-2030
Figure 38: Global Pharmaceutical Quality Management Software Market (Equipment Management), $Million, 2020-2030
Figure 39: Global Pharmaceutical Quality Management Software Market (Others), $Million, 2020-2030
Figure 40: Global Pharmaceutical Quality Management Software Market (by End User)
Figure 41: Global Pharmaceutical Quality Management Software Market Incremental Opportunity (by End User), $Million, 2020-2030
Figure 42: Global Pharmaceutical Quality Management Software Market (Pharmaceutical, Lifesciences, and Biotechnology Companies), $Million, 2020-2030
Figure 43: Global Pharmaceutical Quality Management Software Market (Contract Research Organizations), $Million, 2020-2030
Figure 44: Global Pharmaceutical Quality Management Software Market (Others), $Million, 2020-2030
Figure 45: Global Pharmaceutical Quality Management Software Market (by Deployment Model)
Figure 46: Global Pharmaceutical Quality Management Software Market Incremental Opportunity (by Deployment Model), $Million, 2020-2030
Figure 47: Global Pharmaceutical Quality Management Software Market Growth-Share Matrix (by Deployment Model), 2020-2030
Figure 48: Global Pharmaceutical Quality Management Software Market (On-Cloud), $Million, 2020-2030
Figure 49: Global Pharmaceutical Quality Management Software Market (Web-Based), $Million, 2020-2030
Figure 50: Global Pharmaceutical Quality Management Software Market (On-Premises), $Million, 2020-2030
Figure 51: Global Pharmaceutical Quality Management Software Market Share (by Region), 2020-2030
Figure 52: North America Pharmaceutical Quality Management Software Market Incremental Revenue Opportunity (by Country), $Million, 2020-2030
Figure 53: North America Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 54: North America Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
Figure 55: North America Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
Figure 56: North America Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
Figure 57: U.S. Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 58: Canada Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 59: Europe Pharmaceutical Quality Management Software Market Incremental Opportunity (by Country), $Million, 2020-2030
Figure 60: Europe Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 61: Europe Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
Figure 62: Europe Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
Figure 63: Europe Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
Figure 64: Germany Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 65: U.K. Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 66: France Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 67: Italy Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 68: Spain Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 69: Rest-of-Europe Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 70: Asia-Pacific Pharmaceutical Quality Management Software Market Incremental Revenue Opportunity (by Country), $Million, 2020-2030
Figure 71: Asia-Pacific Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 72: Asia-Pacific Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
Figure 73: Asia-Pacific Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
Figure 74: Asia-Pacific Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
Figure 75: Japan Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 76: China Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 77: South Korea Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 78: India Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 79: Australia and New Zealand Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 80: Rest-of-Asia-Pacific Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 81: Rest-of-the-World Pharmaceutical Quality Management Software Market Incremental Opportunity (by Country), $Million, 2020-2030
Figure 82: Rest-of-the-World Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 83: Rest-of-the-World Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
Figure 84: Rest-of-the-World Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
Figure 85: Rest-of-the-World Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
Figure 86: Brazil Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 87: Mexico Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 88: Rest of Rest-of-the-World Pharmaceutical Quality Management Software Market, $Million, 2020-2030
Figure 89: Global Pharmaceutical Quality Management Software Market, Company Benchmarking
Figure 90: Share of Key Developments and Strategies in the Global Pharmaceutical Quality Management Software Market (by Category), January 2018-August 2021
Figure 91: Global Pharmaceutical Quality Management Software Market, Key Developments, January 2018-August 2021
Figure 92: Global Pharmaceutical Quality Management Software Market, Partnerships, Alliances, and Business Expansions (by Company), January 2018-August 2021
Figure 93: Global Pharmaceutical Quality Management Software Market, New Offerings (by Company), January 2018-August 2021
Figure 94: Global Pharmaceutical Quality Management Software Market, Funding Activities (by Company), January 2018-August 2021
Figure 95: Global Pharmaceutical Quality Management Software Market, Mergers and Acquisitions (by Company), January 2018-August 2021
Figure 96: Global Pharmaceutical Quality Management Software Market, Company Revenue Share Analysis, 2020
Figure 97: ANTARES VISION S.p.A: Overall Financials, 2018-2020
Figure 98: CLARIVATE PLC.: Overall Financials, 2018-2020
Figure 99: Dassault Systèmes: Overall Financials, 2018-2020
Figure 100: Dassault Systèmes: R&D Expenditure, $Million, 2018-2020
Figure 101: Honeywell International Inc.: Overall Financials, 2018-2020
Figure 102: Honeywell International Inc.: R&D Expenditure, $Million, 2018-2020
Figure 103: Ideagen Plc.: Overall Financials, 2018-2020
Figure 104: Ideagen Plc.: R&D Expenditure, $Million, 2018-2020
Figure 105: IQVIA HOLDINGS INC.: Overall Financials, 2018-2020
Figure 106: IQVIA HOLDINGS INC.: R&D Expenditure, $Million, 2018-2020
Figure 107: PTC Inc.: Overall Financials, 2018-2020
Figure 108: PTC Inc.: R&D Expenditure, $Million, 2018-2020
Figure 109: Veeva Systems Inc.: Overall Financials, 2019-2021
Figure 110: Veeva Systems Inc.: R&D Expenditure
Figure 111: Global Pharmaceutical Quality Management Software Market, Research Methodology
Figure 112: Data Triangulation
Figure 113: Assumptions and Limitations
List of Tables
Table 1: Key Barriers and Possible Solutions to Entering the Global Pharmaceutical Quality Management Software Market
Table 2: Global Pharmaceutical Quality Management Software Market Quarterly Key Developments Analysis, January 2018-August 2021
Table 3: Global Pharmaceutical Quality Management Software Market, Exclusion Criteria
Table 4: Global Pharmaceutical Quality Management Software Market, Key Trends
Table 5: Global Pharmaceutical Quality Management Software Market, Cost-Benefit Analysis, $Thousands
Table 6: Case Study: Alphazyme and Qualio
Table 7: Case Study: AL Andalous and AmpleLogic
Table 8: Annual R&D Expenditure of Pharmaceutical Companies
Table 9: Global Pharmaceutical Quality Management Software Market, Opportunity Impact Analysis
Table 10: North America Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
Table 11: North America Pharmaceutical Quality Management Software Market Regulations
Table 12: Europe Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
Table 13: Europe Pharmaceutical Quality Management Software Market Regulations
Table 14: Asia-Pacific Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
Table 15: Asia-Pacific Pharmaceutical Quality Management Software Market Regulations
Table 16: Rest-of-the-World Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
Table 17: Rest-of-the-World Pharmaceutical Quality Management Software Market Regulations
Table 18: ANTARES VISION S.p.A: Product Portfolio
Table 19: AssurX, Inc.: Product Portfolio
Table 20: AXSource: Product Portfolio
Table 21: CLARIVATE PLC.: Product Portfolio
Table 22: ComplianceQuest: Product Portfolio
Table 23: Dassault Systèmes: Product Portfolio
Table 24: EtQ Management Consultants.: Product Portfolio
Table 25: Honeywell International Inc.: Product Portfolio
Table 26: Ideagen Plc.: Product Portfolio
Table 27: IQVIA HOLDINGS INC.: Product Portfolio
Table 28: LogicGate, Inc.: Product Portfolio
Table 29: MasterControl: Product Portfolio
Table 30: PTC Inc.: Product Portfolio
Table 31: Sarjen Systems Pvt. Ltd.: Product Portfolio
Table 32: Qualio: Product
Table 33: Veeva Systems Inc.: Product Portfolio
Samples
LOADING...
Companies Mentioned
- ANTARES VISION S.p.A
- AssurX, Inc.
- AXSource
- CLARIVATE PLC.
- ComplianceQuest
- Dassault Systèmes
- EtQ Management Consultants, Inc.
- Honeywell International Inc.
- Ideagen Plc.
- IQVIA HOLDINGS INC.
- LogicGate, Inc
- MasterControl
- PTC Inc.
- Sarjen Systems Pvt. Ltd.
- Qualio
- Veeva Systems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 205 |
| Published | October 2021 |
| Forecast Period | 2021 - 2030 |
| Estimated Market Value ( USD | $ 585.8 Million |
| Forecasted Market Value ( USD | $ 3717.7 Million |
| Compound Annual Growth Rate | 22.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
